Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.

Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.

Increased tumor-specific CTL activity in human tumor-infiltrating lymphocytes stimulated with autologous tumor lines.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

The p70 tumor necrosis factor receptor mediates cytotoxicity.

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Tumor necrosis factor-alpha in human milk.

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death.

Tumor necrosis factor in human disease.

Interleukin-1 beta induction of tumor necrosis factor-alpha gene expression in human astroglioma cells.

Human astrocytes proliferate in response to tumor necrosis factor alpha.

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Tumor necrosis factor-alpha.

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.

Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes.

Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.

Modulation by novobiocin of sister-chromatid exchanges induced by tumor necrosis factor in human lymphocytes.

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Suggest Documents

Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.

Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.

Increased tumor-specific CTL activity in human tumor-infiltrating lymphocytes stimulated with autologous tumor lines.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

The p70 tumor necrosis factor receptor mediates cytotoxicity.

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Tumor necrosis factor-alpha in human milk.

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death.

Tumor necrosis factor in human disease.

Interleukin-1 beta induction of tumor necrosis factor-alpha gene expression in human astroglioma cells.

Human astrocytes proliferate in response to tumor necrosis factor alpha.

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Tumor necrosis factor-alpha.

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.

Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes.

Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.

Modulation by novobiocin of sister-chromatid exchanges induced by tumor necrosis factor in human lymphocytes.

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

Recommend Documents

Follow Us